These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18214344)

  • 21. [The impact of pioglitazone on plasma homocysteine high-fat diet-induced insulin resistance in rats].
    Yang GQ; Lu JM; Liu HF; Ma FL; Zou XM; Pan CY
    Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):38-41. PubMed ID: 15769396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway.
    Liu J; Shen Q; Wu Y
    Life Sci; 2008 May; 82(19-20):991-6. PubMed ID: 18400235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stimulation of adenosine A1 receptor attenuates angiotensin II induced myocardial hypertrophy in neonatal rats via the extracellular signal-regulated kinase signal pathways].
    Li ZY; Yang YH; Xing L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):698-703. PubMed ID: 24225244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pioglitazone Induces Cardiomyocyte Apoptosis and Inhibits Cardiomyocyte Hypertrophy Via VEGFR-2 Signaling Pathway.
    Zhong W; Jin W; Xu S; Wu Y; Luo S; Liang M; Chen L
    Arq Bras Cardiol; 2018 Aug; 111(2):162-169. PubMed ID: 29972411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
    Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
    Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPARγ-PI3K/AKT-NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin.
    Peng X; Chen R; Wu Y; Huang B; Tang C; Chen J; Wang Q; Wu Q; Yang J; Qiu H; Jiang Q
    J Diabetes Complications; 2015 Aug; 29(6):755-60. PubMed ID: 26045205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.
    Li P; Shibata R; Unno K; Shimano M; Furukawa M; Ohashi T; Cheng X; Nagata K; Ouchi N; Murohara T
    Hypertension; 2010 Jan; 55(1):69-75. PubMed ID: 19933924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EETs/PPARs activation together mediates the preventive effect of naringenin in high glucose-induced cardiomyocyte hypertrophy.
    Zhang J; Qiu H; Huang J; Ding S; Huang B; Zhou P; Jiang Q
    Biomed Pharmacother; 2019 Jan; 109():1498-1505. PubMed ID: 30551401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
    Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
    Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.
    Deng L; Boujdir M; Tremontano A; Pincus MR; El-Sherif N
    Ann Clin Lab Sci; 2009; 39(4):351-60. PubMed ID: 19880762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial alpha-thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene expression.
    Glembotski CC; Irons CE; Krown KA; Murray SF; Sprenkle AB; Sei CA
    J Biol Chem; 1993 Sep; 268(27):20646-52. PubMed ID: 8397212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pioglitazone, a thiazolidinedione derivative, attenuates left ventricular hypertrophy and fibrosis in salt-sensitive hypertension.
    Nakamoto M; Ohya Y; Shinzato T; Mano R; Yamazato M; Sakima A; Takishita S
    Hypertens Res; 2008 Feb; 31(2):353-61. PubMed ID: 18360056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.
    Hou N; Luo MS; Liu SM; Zhang HN; Xiao Q; Sun P; Zhang GS; Luo JD; Chen MS
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1087-95. PubMed ID: 20738325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of PPARgamma by pioglitazone does not attenuate left ventricular hypertrophy following aortic banding in rats.
    Weiss CS; Hagenmüller M; Pichler M; Münz S; Ochs M; Buss SJ; Bekeredjian R; Katus HA; Hardt SE
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):285-95. PubMed ID: 20107770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
    Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
    Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.